Clinical Trial Update: Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dose-attenuated immunosuppressive therapy combined with Hetrombopag in elderly patients (65+) with severe aplastic anemia; rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• CYCLOSPORINE (cyclosporine)
• Hetrombopag (hetrombopag)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Sever Aplastic Anaemia, Elderly (People Aged 65 or More) | Phase 2 | Status: RECRUITING